In Depth 30 Jan 2026 Johnson & Johnson’s pipeline strategy: What does 2026 have in store for the big pharma? Discover J&J’s pipeline strategy for 2026 as it it projects that its sales for the year will be between $100 billion and $101 billion. January 30, 2026 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 30 Jan 2026Building a smart oncology pipeline with Cumulus Oncology Today, our guest is Dr. Clare Wareing, Founder and CEO of Cumulus Oncology, who joins us from Edinburgh. January 30, 2026 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
More News! 16 Jan 2026 JPM 2026: what’s the outlook like this year? This year, JPM 2026 took place again in San Francisco. Let’s look at predictions and trends forecast for 2026, according to attendees at JPM. January 16, 2026 - 13 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 7 Jan 2026 Top biotech deals in December 2025 As we head into the 2026, let’s take a look at biotech licensing deals and M&As that were inked in December 2025. January 7, 2026 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 8 Dec 2025 Top biotech deals in November 2025 An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals space in November. December 8, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 5 Dec 2025Cracking Cancer’s Code: Transforming Research with Novel Cancer Models This week’s guest is Mark Lanasa of BeOne Medicines and we will discuss their novel cancer models and unique in-house R&D approach. December 5, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 3 Dec 2025 Boehringer Ingelheim’s pipeline activity: A busy year of dealmaking for the German pharma in 2025 Discover Boehringer Ingelheim’s pipeline focus areas and how its dealmaking in 2025 has expanded its therapeutic arsenal. December 3, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 1 Dec 2025 Stem cell therapy’s avant-garde: Eight companies leading the way Stem cell therapy has gained traction over the recent years and the market is growing, discover eight companies advancing the field. December 1, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 28 Nov 2025Curing cancer: Daiichi Sankyo’s ambitious ADC approach In today’s episode, Dr. Markus Kosch, Head of the EU Oncology Business Division at Daiichi Sankyo will discuss the company’s approach November 28, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Best in Biotech 19 Nov 2025 Eight CAR-T cell therapy companies you should know about Discover eight promising companies advancing their CAR-T cell therapy candidates in the clinic and have made the headlines in 2025. November 19, 2025 - 16 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 14 Nov 2025Meet Fusix Biotech: 2025 BIO-Europe Startup Spotlight champion revolutionizing oncology Labiotech sat down with Jennifer Altomonte, co-founder of the BioEurope Startup Spotlight finalist, Fusix Biotech, who discussed Fusix’s cancer platform technology. November 14, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Sponsored by Biocon Biologics 13 Nov 2025 Biosimilars: a vital remedy for Europe’s healthcare challenges Discover how biosimilars in Europe expand access, cut costs, and strengthen healthcare systems for a more sustainable future. November 13, 2025 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email